ZEB2 and breast cancer: By preventing ZEB2 (zinc finger E-box-binding homeobox 2) expression, miR-200b/c stimulates the mesenchymal-to-epithelial cell transition (MET) and increases macroscopic metastases in BC cell lines (38).